<?xml version="1.0"?> 
<rss version="2.0">

	<channel>
		<title>Avadel Pharmaceuticals plc (AVDL) research, news, and more from GeoInvesting</title>
		<description>The latest research, news, and more from GeoInvesting for Avadel Pharmaceuticals plc (AVDL)</description>
		<link>/companies/avdl_avadel_pharmaceuticals_plc/overview</link>
		<language>en-us</language>
		<pubDate>Wed, 29 Apr 2026 09:25:38 GMT</pubDate>
		<lastBuildDate>Wed, 29 Apr 2026 09:25:38 GMT</lastBuildDate>
        <ttl>120</ttl>
        
        <item><title>Company description</title><guid isPermaLink="false">53466</guid><pubDate>Wed, 30 Jul 2008 04:00:00 GMT</pubDate><description>Flamel Technologies S.A. is principally engaged in the development of advanced polymer technologies for unique medicinal applications. To meet important medical needs and develop commercially valuable products, they are building on their primary technology platforms: the Medusa system for the controlled peritoneal delivery of proteins and peptides, and the Micropump system for the controlled delivery of certain oral drugs. (press release)</description><link>/companies/avdl_avadel_pharmaceuticals_plc/overview</link></item>
            
	
	</channel>  
	
</rss>
